Vir Biotechnology, Inc 10-Q for FY2023 Q1
Vir Biotechnology, Inc. (VIR)
10-Q
2023-05-08
For: 2023-03-31
View Original
Added on
April 09, 2026
About this 10-Q
Vir Biotechnology, Inc filed this 10-Q on May 8, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $62.96M
- down 94.9% from $1.23B a year earlier
- Net loss
- $140.96M
- compared with net income of $518.62M a year earlier
- Diluted EPS
- -$1.06
- compared with $3.85 a year earlier